Please login to the form below

deafness

This page shows the latest deafness news and features for those working in and with pharma, biotech and healthcare.

and a host of other complications including blindness, deafness, learning disabilities and pain.

BioMarin's real world data sways NICE on orphan drug Vimizim

heart disease, dental and eye care, pain relief, and hearing aids and ventilating tubes to manage deafness and middle ear effusions. .
Hearing loss prevention drugs expected by 2020

Report by Action on Hearing Loss launched today
NICE backs Roche's MabThera in rare autoimmune disease

indication, with ANCA-associated vasculitis an umbrella term for several related conditions that usually affect the lungs, kidneys, ears, nose or sinuses, sometimes leading to organ damage, bleeding or deafness.
Novartis wins childhood arthritis indication for Ilaris in EU

The approval adds to Ilaris' existing approvals in the EU to treat the rare inflammatory disorder cryopyrin-associated periodic syndromes (CAPS), which can lead to deafness and loss of vision, and
Sanofi and Audion in hearing partnership

approach. The research will use technology developed at the Massachusetts Eye and Ear Infirmary in the Eaton-Peabody Laboratory, a basic research facility dedicated to the study of hearing and deafness,

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Significant figures

The liposome technology creates a shield that keeps most of the drug out of direct contact with a patient’s blood, successfully dodging Amikacin’s severe side effects, which include deafness,
The impending threat of antibiotic resistance

Pneumonia. 1 in 3 people died. Ear infection. Caused deafness. Surgery.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Add my company

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
The evolution of real-world studies: How industry and regulators are using real-world data...